NCT07569796 Effectiveness of Stimulation on the Sciatic Nerve in ACLR
| NCT ID | NCT07569796 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de Murcia |
| Condition | Anterior Cruciate Ligament Reconstruction Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After randomization, the control group will receive conventional physiotherapy, including manual therapy and therapeutic exercise for ACL rehabilitation. The first experimental group will undergo percutaneous electrical nerve stimulation of the sciatic nerve, while the second experimental group will receive a placebo stimulation. Both interventions aim to improve isometric strength, muscle activation, joint range of motion, and thigh circumference, as well as reduce pain and intra-articular effusion. The procedure involves needle insertion into the sciatic nerve epineurium, placement of a surface electrode on the hamstrings, and connection to an electrostimulator.
Eligibility Criteria
Inclusion Criteria: * Use of the Semitendinous and Gracilis tendons for ACL Reconstruction * Joint Range of Motion greater than or equal to 90 * Primary ACL injury in the leg to be treated Exclusion Criteria: * Chronic or rheumatic joint disease * Central nervous system disorder * Heart disease (pacemaker) * Neoplasms * Epilepsy * Coagulopathies (use of anticoagulants) * History of spinal surgery or lumbar disease * History of neurological disorders * Prosthesis or osteosynthesis in the operated leg * Structural discrepancy in lower-limb length * Belonephobia (overwhelming fear of needles) * Neuropathic pain or bilateral symptoms * Use of analgesics * Quadriceps tendon graft harvest * Body mass index \<20 or \>30 kg/m² * Acute muscle injuries * Knee joint instability * Acute joint inflammation
Frequently Asked Questions
Who can join the NCT07569796 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Anterior Cruciate Ligament Reconstruction Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07569796 currently recruiting?
Yes, NCT07569796 is actively recruiting participants. Visit ClinicalTrials.gov or contact Universidad de Murcia to inquire about joining.
Where is the NCT07569796 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT07569796 clinical trial?
NCT07569796 is sponsored by Universidad de Murcia. The trial plans to enroll 62 participants.